Notably, the p53/miR-34a/SIRT1 positive feedback loop can inhibit cell proliferation and promote apoptosis, providing a potential therapeutic alternative for p53-wild-type HCC patients (Gong et al., 2023). The gene discussed is TP53; the disease is hepatocellular carcinoma.